Is radiofrequency ablation effective in patients with early-stage hepatocellular carcinoma and cirrhosis?
Goldberg
S Nahum
SN
Minimally Invasive Tumor Therapy Laboratory, Beth Israel Deaconess Medical Center, and Harvard University, Boston, MA 02215, USA. sgoldber@bidmc.harvard.edu